EUVIMEDEUVIMED entdecken
Crossref

Development of Magnetite-Graphene Oxide Nanoplatforms for pH-Sensitive Doxorubicin Delivery and Cytotoxicity Evaluation

Nizamudin Hussien, Enes Güncüm, Nuran Işiklan, Mustafa Türk

Turkish Journal of Veterinary Research · 29.03.2026 · 10 (1) · 101-109

DOI: 10.47748/tjvr.1842580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Veterinary Research, online erschienen am 29.03.2026. Verfasst von Nizamudin Hussien und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Scientific Research Projects Coordination Unit of Kırıkkale University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to develop and characterize a magnetite-graphene oxide (m-GO) nanoplatform for the controlled, pH-sensitive delivery of doxorubicin (DOX), with an emphasis on improving targeted anticancer activity and minimizing systemic toxicity. The potential application of this system in both human and veterinary oncology was also considered. Materials and Methods: Magnetite-functionalized graphene oxide (m-GO) nanoparticles were synthesized by decorating graphene oxide with Fe₃O₄ nanoparticles. DOX was loaded onto the m-GO system, and the loading was confirmed by UV-Vis and FTIR spectroscopy. The nanoparticles were characterized for particle size and zeta potential. In vitro drug release studies were conducted at pH 5.5 and 7.4 to assess pH sensitivity. Cytotoxic effects were evaluated using the MTT assay on MCF-7 human breast cancer cells. Drug release kinetics were also analyzed to determine the release mechanism.

Results

The synthesized nanoparticles had a mean particle size of 42.18 ± 4.22 nm and a zeta potential of −19.3 ± 1.54 mV. Drug release studies showed enhanced DOX release at acidic pH (5.5), indicating pH sensitivity. The MTT assay demonstrated dose-dependent cytotoxicity, with free DOX showing immediate higher toxicity, while DOX-loaded m-GO provided controlled cytotoxic effects. Release kinetics analysis revealed a Fickian diffusion-controlled mechanism.

Conclusion

DOX-loaded m-GO nanoparticles exhibited favorable physicochemical properties and pH-sensitive drug release behavior. Their ability to provide controlled drug delivery with sustained cytotoxicity suggests that they may serve as promising nanocarrier systems for targeted cancer therapy, with potential applications in both human and veterinary medicine.

Förderung

  • Scientific Research Projects Coordination Unit of Kırıkkale University

Zitieren

APA

Hussien, N., Güncüm, E., Işiklan, N., & Türk, M. (2026). Development of Magnetite-Graphene Oxide Nanoplatforms for pH-Sensitive Doxorubicin Delivery and Cytotoxicity Evaluation. Turkish Journal of Veterinary Research, 10(1), 101-109. https://doi.org/10.47748/tjvr.1842580

Vancouver

Hussien N, Güncüm E, Işiklan N, Türk M. Development of Magnetite-Graphene Oxide Nanoplatforms for pH-Sensitive Doxorubicin Delivery and Cytotoxicity Evaluation. Turkish Journal of Veterinary Research. 2026;10(1):101-109. doi:10.47748/tjvr.1842580

BibTeX
@article{Hussien2026,
  author = {Hussien, Nizamudin and Güncüm, Enes and Işiklan, Nuran and Türk, Mustafa},
  title = {Development of Magnetite-Graphene Oxide Nanoplatforms for pH-Sensitive Doxorubicin Delivery and Cytotoxicity Evaluation},
  journal = {Turkish Journal of Veterinary Research},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {101--109},
  doi = {10.47748/tjvr.1842580}
}
Kostenlos starten →